DBD — Diebold Nixdorf Income Statement
0.000.00%
- $2.43bn
- $3.10bn
- $3.75bn
- 92
- 79
- 97
- 99
Annual income statement for Diebold Nixdorf, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3,902 | 3,905 | 3,461 | 3,761 | 3,751 |
| Cost of Revenue | |||||
| Gross Profit | 1,057 | 1,059 | 778 | 876 | 948 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 3,878 | 3,768 | 3,705 | 2,077 | 3,576 |
| Operating Profit | 24 | 137 | -244 | 1,684 | 175 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -270 | -50.7 | -439 | 1,448 | 47.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -269 | -78.4 | -588 | 1,373 | -17 |
| Minority Interest | |||||
| Equity in Affiliates | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -269 | -78.8 | -581 | 1,376 | -16.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -269 | -78.8 | -581 | 1,376 | -16.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -2.63 | -0.736 | -5.2 | 10.1 | 1.5 |
| Dividends per Share |